Back to Search
Start Over
SO-32 Biomarker analysis of the phase III IMblaze370 trial of atezolizumab plus cobimetinib or atezolizumab monotherapy vs regorafenib in third-line CRC
- Source :
- Annals of Oncology. 31:S229
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
Details
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........3cbf63f594eed2a7a3c7efd5536db07e
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.04.047